FDA warned Iodine Products Inc that its Liquid Mask and COVID-Killer sprays are unapproved drugs with illegal COVID-19 claims.
What happened
FDA reviewed Iodine Products Inc’s website on March 2, 2022, and its YouTube, Facebook, and Instagram pages, which direct consumers to the site; FTC reviewed the website on March 23, 2022. FDA found the company offered Liquid Mask Spray Anti-Viral and The COVID-Killer for sale in the U.S. with claims that they mitigate, prevent, treat, diagnose, or cure COVID-19. FDA says these are unapproved new drugs and misbranded drugs (drugs with illegal labeling or claims).
What FDA found
The company sold products with COVID-19 claims without FDA approval.
Federal Food, Drug, and Cosmetic Act section 505(a), 21 U.S.C. § 355(a)The products are misbranded drugs because their labeling and promotion include illegal claims.
Federal Food, Drug, and Cosmetic Act section 502, 21 U.S.C. § 352The company introduced or delivered the products for introduction into interstate commerce, which the law prohibits for these products.
Federal Food, Drug, and Cosmetic Act sections 301(a) and (d), 21 U.S.C. § 331(a) and (d)The company advertised that its products can prevent, treat, or cure COVID-19 without competent and reliable scientific evidence.
FTC Act, 15 U.S.C. § 41 et seq.The company’s deceptive COVID-19 claims may bring civil penalties under the COVID-19 Consumer Protection Act.
COVID-19 Consumer Protection Act, Section 1401, Division FF, Consolidated Appropriations Act, 2021, P.L. 116-260
What FDA wants
FDA asks the company to immediately stop selling any unapproved and unauthorized products for COVID-19 and, within 48 hours, email FDA with the steps taken to correct the violations and prevent recurrence. FTC also asks for certification within 48 hours that the company has stopped making unsubstantiated claims.
Who should pay attention
- online sellers of health products
- companies making iodine or antiviral sprays with disease claims
- marketing and compliance teams handling COVID-19 claims
This is a summary. Read the original letter on fda.gov.